Company intelligence / Profile preview

Imagen Technologies

New York City, New York, United Statesimagen.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Imagen Technologies provides FDA-cleared, AI-powered diagnostic imaging solutions for primary care practices. Their platform enables on-site screening and interpretation of medical images such as X-rays, mammography, and fundoscopy. The technology aims to improve early detection rates and reduce missed diagnoses by supporting clinicians with advanced image analysis tools. Clinical results cited include significant reductions in life-threatening clinical misses and increased detection rates for certain conditions like aortic atherosclerosis.

Modalities: DeviceSoftware
Industry: Medical Imaging

Beyond the preview

Go deeper on Imagen Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imagen Technologies.

Explore the full profile